Commercial Bromelain as an Anticoagulant / (Record no. 9085)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03023nam a22003137a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | PILC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240720152743.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 160505b2013 xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | FEU-NRMF MEDICAL LIBRARY |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | MT 2013 0002 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Alicia A. Aldave, RMT |
| Relator term | adviser |
| 111 ## - MAIN ENTRY--MEETING NAME | |
| Date of meeting | September 2013 |
| 245 ## - TITLE STATEMENT | |
| Title | Commercial Bromelain as an Anticoagulant / |
| Statement of responsibility, etc. | Andre Vinzon I. Baldovino ; Mark Jeffrey C. Merced ; Audilyn P. Montano ; Venice Vernadette SJ. Nicolas ; Rommel Banjo Q. Pangan and Pia Karla S. Tempongko. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | Fairview, Quezon City |
| Name of publisher, distributor, etc. | School of Medical Technology, FEU-NRMF |
| Date of publication, distribution, etc. | September 2013 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 28 pages: |
| Other physical details | illustrations, tables, photos; |
| Dimensions | 28 cm. |
| 336 ## - CONTENT TYPE | |
| Source | rdacontent |
| Content type term | text |
| 337 ## - MEDIA TYPE | |
| Source | rdamedia |
| Media type term | unmediated |
| 338 ## - CARRIER TYPE | |
| Source | rdacarrier |
| Carrier type term | volume |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes appendices and bibliographical references. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Abstract: The goal of the study is to prove that bromelain has an anticoagulant property in vitro. Bromelain is an enzyme coming from the pineapple proven by other studies to have an anticoagulant effect. It possesses anticoagulant properties in vivo which reduce the ability of platelets to clump together, or aggregate, reports a paper published in the January-February 1999 issue of the medical journal "in Vivo" In the attempt to give a broader source of anticoagulant, the researchers thought of utilizing the commercialized pure and natural bromelain powder. The researchers determined the blood to anticoagulant ratio by means of trial and error method, using EDTA as the positive and whole blood as negative control. Bromelain powder was diluted to varying volumes of NSS to attain different anticoagulant concentrations. They determined the length of time of the anticoagulant activity of the bromelain by recording the time on which no clotting occurs after examining the presence and absence of clot formation. Then morphology was tested with the use of Wright and Giemsa staining technique. After subjecting specimens of blood to series of bromelain concentration the results showed anticoagulant activities that lasted from more than 24 minutes to less than 6 hours, but denied of positive findings due to use of EDTA as positive control. Also, the results showed that blood cells with bromelain powder were morphologically similar as that of blood cells using EDTA. Therefore the researchers concluded that the commercially prepared bromelain has an anticoagulant property. It had a longer anticoagulant activity than the negative control and no morphologic changes were noted in blood smear with bromelain as compared with EDTA. The blood cells with bromelain have the same appearance as that of EDTA. |
| 521 ## - TARGET AUDIENCE NOTE | |
| Target audience note | Thesis - School of Medical Technology |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Baldovino, Andre Vinzon |
| Relator term | author |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Merced, Mark Jeffrey C. |
| Relator term | author |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Montano, Audilyn P. |
| Relator term | author |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nicolas, Venice Vernadette SJ. |
| Relator term | author |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pangan, Rommel Banjo Q. |
| Relator term | author |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tempongko, Pia Karla S. |
| Relator term | author |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Library of Congress Classification |
| Koha item type | Theses |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Library of Congress Classification | Far Eastern University - Nicanor Reyes Medical Foundation | Far Eastern University - Nicanor Reyes Medical Foundation | Theses | 02/11/2015 | MT 2013 0002 | T001111 | 03/25/2015 | 07/22/2016 | Theses | |||||
| Library of Congress Classification | Far Eastern University - Nicanor Reyes Medical Foundation | Far Eastern University - Nicanor Reyes Medical Foundation | Theses | 03/02/2017 | MT 2013 0002 c.2 | T001570 | 03/02/2017 | 03/02/2017 | Theses |
